#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast cancer metastatic Metastases to central nervous system Immune-mediated myasthenia gravis Hereditary motor and sensory neuropathy Cutaneous lupus erythematosus Congenital megacolon Palmar-plantar erythrodysaesthesia syndrome Orthostatic hypotension Adenomatous polyposis coli Deafness bilateral Immune-mediated renal disorder Spinal cord injury cervical Indolent systemic mastocytosis Wolfram syndrome Leiomyosarcoma More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Basic Information Langerhans’ cell histiocytosis – Trials in Disease Congenital hypotransferrinaemia – Basic Information Mantle cell lymphoma – Basic Information Methylmalonic acidaemia – Basic Information Lymphangioma – Basic Information Richter’s syndrome – Life with Disease Mantle cell lymphoma refractory – Trials in Disease Lysosomal storage disorder – Basic Information Inclusion body myositis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Resomelagon Asundexian Sulodexide GSKVX000000040033 F44/10 Argon HAFNIUM OXIDE L-Ascorbic Acid Exenatide Sodium Iodide RP2 Iptacopan Hydrochloride Quinidine Sulfate Rbd5044 Sodium Sodium Glycerophosphate Human Coagulation Factor Vii Namilumab Triptorelin Acetate Larotrectinib Sulfate Kd050 More therapies…

    Learn about Your Condition

    Cancer fatigue Medullary thyroid cancer Laparotomy Tachypnoea Neuromyopathy Hypertension Hypopituitarism Type IIa hyperlipidaemia Hodgkin's disease refractory Vascular graft thrombosis Colon cancer stage III Pulmonary fibrosis Endocrine disorder Childhood asthma Mitral valve incompetence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Influenza

  • Study on Immune Responses to Avian Influenza Vaccine with A/Turkey/Turkey/1/05 (H5N1)-Like Strain in Patients with Avian and Seasonal Influenza

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • A/TURKEY/TURKEY/1/05 (H5N1)-LIKE STRAIN (NIBRG-23)
    • Influenza Virus A/Darwin/9/2021 San-010 (H3N2)
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    Finland
  • Study on the Effectiveness of High-Dose vs. Standard-Dose Quadrivalent Influenza Vaccine in Preventing Flu in Adults Aged 65-79 in Galicia, Spain

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224)
    • B/Washington/02/2019 – Like Virus (B/Washington/02/2019, Wild Type)
    • A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
    Spain
  • Study on Baloxavir Marboxil for Children with Influenza

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • Baloxavir Marboxil
    Bulgaria Poland Spain
  • Safety and immune response of OVX836C2 vaccine compared with drug combination in healthy adults with influenza

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • INFLUENZA A (H1N1/WSN/1933) NUCLEOPROTEIN FUSED TO C-TERMINAL FRAGMENTS OF TWO AVIAN C4BP ALFA CHAIN SEQUENCES
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • Influenza Virus B/Michigan/01/2021
    Belgium
  • Effectiveness of mCOMBRIAX vaccine compared with high‑dose influenza vaccine and mRNA‑1273 in adults ≥65 years for prevention of influenza and COVID‑19

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • Influenza Virus B/Michigan/01/2021
    • B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)
    Denmark Spain
  • Early Use of Dexamethasone versus Sodium Chloride Placebo in Patients with Severe Influenza-Induced Acute Hypoxemic Respiratory Failure (Phase III Randomized Trial)

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Influenza
    • Pneumonia
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    France
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!